Two scars that look similar at first inspection may require different treatments because their depth, architecture, fixation and tissue response are different.
Distinguish ice-pick, boxcar, rolling and mixed patterns rather than grouping all depressed scars into a single category.
Establish whether the dominant abnormality is superficial, dermal or associated with deeper architectural change.
Evaluate tethering, fibrotic anchoring and loss of tissue mobility because these features can limit the effect of surface treatment alone.
Consider skin phototype, pigmentary response, active inflammation, previous procedures and expected recovery before selecting treatment intensity.
Rapid visual differentiation of the principal atrophic acne scar patterns before treatment selection and sequencing.
Before scar correction: active acne, clinically significant inflammation and factors likely to interfere with predictable healing should be addressed before undertaking an aggressive scar-remodeling sequence.
Protocol selection begins with the dominant scar component. The purpose of this overview is to identify which therapeutic pathway best corresponds to the anatomy and biological objective established during the diagnostic phase.
A controlled chemical pathway directed primarily toward superficial scar expression, texture irregularity and selected epidermal or superficial dermal components.
A targeted chemical strategy used when controlled resurfacing and a staged tissue response are required within the treatment sequence.
A more intensive resurfacing pathway considered when scar architecture requires a stronger intervention at the surface and superficial structural levels.
A combined strategy reserved for selected complex cases in which deeper tissue dynamics coexist with surface scar pathology and therefore require actions at more than one anatomical level.
The most intensive protocol is not automatically the most appropriate. Treatment intensity should follow scar architecture, tissue target, expected biological response and the patient's capacity for predictable recovery.
Selected superficial textural abnormalities and mixed scar patterns in which focal deeper defects coexist with a broader field of irregular surface relief.
A predominantly surface-oriented chemical procedure cannot by itself correct significant fibrotic tethering or major subdermal architectural distortion. When a deeper biological component is required, α-lipoic acid (Lipoic Acid) is integrated into the treatment sequence, while true structural fixation may require a different therapeutic modality.
Integrated view of pre-treatment preparation, controlled chemical remodeling, post-procedure recovery and deeper biological support.
Used during skin preparation to support cutaneous hygiene, microbiome control and normalization of the treatment field before chemical intervention.
Used for controlled surface conditioning before the procedure, helping to establish a more homogeneous epidermal treatment field.
Integrated during the preparatory phase whenever deeper tissue conditioning and metabolic support are required. Its role is to accompany the deeper biological component of the treatment strategy before procedural remodeling.
If the clinical objective extends beyond simple surface conditioning, α-lipoic acid (Lipoic Acid) becomes an integral component of the preparatory sequence rather than an optional adjunct.
Confirm that active inflammation has been adequately controlled, reassess scar morphology and determine whether the planned procedure should remain predominantly superficial or include a deeper tissue-remodeling strategy.
Reserved strictly for true, appropriately selected ice-pick defects rather than applied indiscriminately to every depressed acne scar.
May be incorporated when a broader superficial remodeling action is clinically justified by the surrounding scar topography and skin condition.
Applied immediately after the procedural chemical phase according to the established protocol, with the objective of harmonizing the treatment field and the post-application response.
The procedural chemical action addresses the selected surface and focal scar architecture, while the metabolic component established with α-lipoic acid (Lipoic Acid) accompanies the deeper biological remodeling pathway.
Incorporated into the post-procedure strategy to support the treated surface during the early recovery phase and accompany controlled epidermal restoration.
Used for intensive hydration and barrier support during the early recovery and re-epithelialization period.
Integrated after the procedure as the deeper metabolic component of recovery, accompanying tissue remodeling beyond the superficial re-epithelialization phase and supporting biological consolidation of the treatment response.
Once the immediate surface recovery has begun, α-lipoic acid (Lipoic Acid) continues the metabolic component of the protocol whenever deeper remodeling remains part of the therapeutic objective.
Allow both superficial healing and the deeper biological response to evolve before deciding whether another chemical session or a different therapeutic modality is required.
Focal defects, surface irregularity and deeper biological remodeling represent different therapeutic targets. Treatment intensity and product sequencing should therefore be distributed according to scar morphology, tissue depth and the biological objective established before the procedure.
The procedural chemical phase primarily addresses selected scar surface and superficial architecture. Whenever the therapeutic objective extends into deeper tissue biology, α-lipoic acid (Lipoic Acid) is integrated both before and after the procedure as part of the metabolic preparation and consolidation sequence.
The protocol therefore follows a multilevel logic rather than treating the entire scar as a single anatomical problem.
Relief is homogenized first. Chemical intensity is then graduated according to the scar zone rather than uniformly applied across the entire treatment field.
Irregular acne scar fields in which differences in relief, lesion depth and surrounding skin architecture create marked contrast between scars and adjacent tissue.
Reduce relief heterogeneity first, create a more uniform treatment substrate, then distribute TCA concentration according to lesional, peri-lesional and transition zones.
Er:YAG relief leveling followed by graduated TCA photodetersion, immediate Peeling de Luxe Plus application, structured recovery and metabolic consolidation.
Used to support cutaneous hygiene, microbiome control and normalization of the treatment field before resurfacing.
Provides controlled surface conditioning and contributes to a more homogeneous epidermal preparation before the procedure.
Integrated during preparation when deeper tissue conditioning and metabolic support are part of the treatment objective.
When the planned response extends beyond simple surface conditioning, α-lipoic acid (Lipoic Acid) becomes part of the preparatory sequence.
Confirm control of inflammation and reassess scar morphology, relief heterogeneity and treatment depth before proceeding.
A superficial Er:YAG pass is performed first to level surface relief and reduce the contrast between depressed scars and surrounding skin.
TCA concentration is distributed according to the anatomical relationship between the scar and surrounding tissue.
Applied immediately after controlled frosting as the final procedural step in the treatment sequence.
Controlled TCA frosting on crusts is therapeutically intentional and should not be interpreted as an accidental or secondary event.
Supports the treated surface during early recovery and accompanies controlled epidermal restoration and photoprotection.
Provides intensive hydration and barrier support during the early post-procedure and re-epithelialization period.
Maintains the metabolic component between sessions, supporting mitochondrial activity and deeper dermal remodeling during biological consolidation.
Structured redox support is maintained between sessions whenever deeper biological remodeling remains part of the therapeutic goal.
Evaluate tolerance, healing and scar response before progressing to the next weekly session.
Sushi Peel does not begin by increasing chemical aggression. It begins by reducing relief heterogeneity with superficial Er:YAG, then graduates TCA concentration according to the anatomical zone. The biological response is subsequently consolidated through structured recovery and metabolic support.
Surface equalization comes first. Chemodermabrasion does not begin by escalating treatment depth; it first reduces topographic irregularity mechanically, then adapts chemical action to the remodeled surface.
Complex post-acne topography with pronounced surface irregularity, scar-edge discontinuity and relief heterogeneity where mechanical leveling can improve the substrate before chemical remodeling.
Reduce topographic contrast first, create a more homogeneous surface architecture, then apply chemical modulation according to the remaining scar pattern and tissue response.
Mechanical relief leveling followed by adapted chemical modulation, Peeling de Luxe Plus, structured re-epithelialization and metabolic consolidation.
Supports cutaneous hygiene, microbiome control and normalization of the treatment field before mechanical and chemical intervention.
Provides controlled surface conditioning and contributes to a more homogeneous epidermal preparation before treatment.
Integrated during preparation when deeper tissue conditioning and metabolic support are required as part of the planned remodeling response.
When the therapeutic objective includes deeper remodeling, α-lipoic acid (Lipoic Acid) accompanies the preparatory phase rather than assigning penetration-related objectives to surface conditioning alone.
Reassess active inflammation, scar topography, skin condition, tissue depth and the extent of mechanical leveling required.
Irregular scar zones are mechanically leveled in a controlled manner to reduce abrupt topographic transitions and improve surface uniformity.
TCA is subsequently adapted to the residual topography and the biological response required from the remodeled treatment field.
Applied after the procedural phase to harmonize the treatment response and accompany the chemically modulated surface.
The objective is surface equalization first — not depth escalation. Treatment depth is not increased simply because scar topography is severe.
Supports the recovering surface during re-epithelialization and provides structured photoprotection during early healing.
Provides intensive hydration and barrier support throughout the re-epithelialization period.
Structured redox modulation is maintained during consolidation, supporting mitochondrial activity and deeper dermal reorganization after surface equalization.
The procedural correction of surface topography is followed by biological consolidation whenever deeper remodeling remains part of the therapeutic objective.
The remodeled surface should be allowed to mature before deciding whether additional resurfacing or another modality is required.
Scientifically, however, chemodermabrasion remains a coherent strategy for complex post-acne topography when mechanical leveling, chemical modulation, recovery and metabolic consolidation are integrated within a structured treatment framework.
Chemodermabrasion treats topography before attempting greater depth. Mechanical leveling reduces abrupt surface irregularity, chemical modulation acts on the newly organized treatment field, and subsequent recovery and metabolic support consolidate the remodeling response.
Treat each anatomical level with the modality designed for that level. Deeper tissue behavior is addressed first when clinically dominant; surface irregularity is then remodeled with the appropriate chemical strategy.
Selected mixed acne-scar patterns in which altered deeper tissue mechanics or structural behavior coexist with visible epidermal and dermal surface irregularity.
Separate deeper and superficial therapeutic targets, assign a specific modality to each one, and sequence the interventions so that tissue mechanics and surface remodeling work synergistically.
Deeper tissue modulation combined with morphology-driven chemical resurfacing, structured recovery and metabolic consolidation.
Identify deeper mechanical or structural behavior contributing to distortion of the scar field.
Evaluate dermal loss, scar-edge architecture and the need for biological remodeling within the intermediate tissue level.
Address texture, superficial irregularity and visible topographic contrast with an appropriate chemical protocol.
Supports cutaneous hygiene and normalization of the treatment field before the surface component of the protocol.
Provides controlled surface conditioning in preparation for the subsequent chemical treatment phase.
Integrated when deeper tissue conditioning and metabolic support are part of the planned multilevel remodeling strategy.
Because this protocol explicitly includes a deeper biological objective, α-lipoic acid (Lipoic Acid) belongs within the preparatory sequence rather than being treated as a secondary adjunct.
Separate the deeper tissue target from the dermal and surface components before deciding the treatment sequence.
Used in selected cases to address the deeper tissue component contributing to abnormal tissue mechanics and distortion of the scar field.
Once the deeper component has been addressed, the remaining surface irregularity is reassessed rather than automatically treated with a predetermined peel intensity.
The chemical component is selected according to the residual surface architecture, scar morphology and required degree of controlled resurfacing.
Myomodulation addresses the deeper tissue component; the peel addresses surface and selected dermal scar expression. The two modalities should complement rather than duplicate each other.
Supports the chemically treated surface during early recovery and accompanies structured photoprotection.
Provides hydration and barrier support during re-epithelialization after the surface component of treatment.
Maintains the deeper metabolic component during consolidation, supporting tissue reorganization after the combined treatment sequence.
Recovery should be assessed at both the surface and deeper tissue levels before additional intervention is planned.
Allow the combined tissue response to evolve before deciding whether further peeling, deeper treatment or observation is the most appropriate next step.
Myomodulation + Peels is not a simple combination of procedures. It is a multilevel strategy in which deeper tissue behavior and surface scar expression are diagnosed separately, treated with different actions and then reassessed as a coordinated biological response.
The correct question is not “Which products are used for acne scars?” but “Which product belongs at this stage, for this tissue target, within this specific protocol?”
Used during the preparatory phase to support cutaneous hygiene, microbiome control and normalization of the treatment field before procedural intervention.
Provides controlled surface conditioning before treatment and helps establish a more homogeneous epidermal substrate for the planned procedural phase.
Integrated whenever the protocol extends beyond superficial conditioning and includes deeper tissue preparation, redox support or biological consolidation between procedural sessions.
Dedicated magistral formulation used within the Myomodulation protocol when deeper dynamic tissue reshaping is required before subsequent surface refinement with chemical peeling.
Used immediately after selected procedural chemical phases to harmonize the treatment field and accompany the transition from active treatment to controlled recovery.
Incorporated during the early post-procedure phase to accompany epidermal recovery and structured photoprotection of the treated surface.
Provides intensive hydration and barrier support during the re-epithelialization period following chemical resurfacing or chemodermabrasion.
Aseptiskin → PrePeel → α-lipoic acid (Lipoic Acid) when deeper support is required → controlled chemical treatment → Peeling de Luxe Plus → Stretchpeel + Les Félins → metabolic consolidation.
Aseptiskin → PrePeel → α-lipoic acid (Lipoic Acid) → Er:YAG relief leveling → graduated TCA → Peeling de Luxe Plus → Stretchpeel + Les Félins → metabolic support between sessions.
Aseptiskin → PrePeel → α-lipoic acid (Lipoic Acid) → mechanical leveling → adapted chemical modulation → Peeling de Luxe Plus → Stretchpeel + Les Félins → metabolic consolidation.
Aseptiskin + PrePeel for surface preparation → α-lipoic acid (Lipoic Acid) for deeper metabolic preparation → licensed magistral Myomodulation product → reassessment → morphology-driven peel → recovery and consolidation.
The deeper Myomodulation component should not be represented as a generic injectable procedure. It uses its dedicated licensed magistral product as part of the dynamic tissue-reshaping strategy. The objective is the characteristic skin-stretching and smoothing effect before residual surface irregularity is reassessed and, when indicated, refined with the appropriate peel.
Product sequencing follows anatomy and biological timing. Preparation, procedural treatment, surface recovery and deeper consolidation should not be collapsed into a single step, and the Myomodulation magistral formulation has a distinct role from products used for chemical peeling.
Identify the dominant problem first: superficial irregularity, heterogeneous scar relief, complex topography or deeper tissue distortion. Then select the protocol designed for that specific anatomical target and integrate protection according to the biological vulnerability of the treatment field.
The dominant problem is selected superficial scar expression, textural irregularity or focal chemical targets without major global topographic distortion.
Controlled chemical treatment distributed according to scar morphology, with α-lipoic acid (Lipoic Acid) integrated whenever deeper metabolic support is required.
Surface-oriented chemical treatment alone to correct major tethering or predominantly deeper structural distortion.
Scar relief is heterogeneous and the contrast between lesional, peri-lesional and surrounding skin makes uniform chemical application biologically less rational.
Superficial Er:YAG relief homogenization followed by graduated TCA photodetersion: 18% lesional, 15% peri-lesional and 12% transition zones.
Homogenize the relief first; graduate chemical intensity second.
Complex post-acne topography, scar-edge discontinuity and pronounced surface irregularity require direct mechanical equalization before chemical modulation.
Controlled mechanical dermabrasion followed by TCA adapted to the residual topography and subsequent biological consolidation.
Surface equalization first — not automatic depth escalation.
Deeper tissue distortion, folds or altered tissue mechanics coexist with residual scar-surface irregularity.
Myomodulation first produces dynamic tissue reshaping and a skin-stretching effect; residual surface abnormalities are then reassessed and treated with the appropriate peel.
Smooth the deeper tissue field first, then refine the remaining surface irregularity.
Kosmopeel is the principal protective product when treatment planning requires preservation of both the basal layer and the superficial lipid layer. Its role is therefore not simply corrective, but protective: it supports the biological integrity of the skin while the scar-remodeling strategy is being selected, performed and consolidated.
The most aggressive protocol is not automatically the best protocol. The optimal strategy is the one that corrects the dominant anatomical problem with the least unnecessary tissue aggression, preserves the biological integrity of the skin, and allows reassessment before the next therapeutic decision.
When protection of both the basal layer and the superficial lipid layer is a priority, Kosmopeel should be considered the principal protective reference within the treatment strategy.
One 30 Min Peel Off Session · Immediate Post-Treatment Evaluation
This case documents the immediate epidermal response observed in a patient presenting with established post-acne atrophic scars, enlarged pores and irregular surface texture. The photographs were obtained before treatment and immediately after one 30 Min Peel Off session.
Clinical reality: the immediate improvement primarily concerns epidermal smoothness, luminosity and the optical visibility of superficial irregularities. A single superficial session must not be interpreted as definitive correction of established atrophic acne scars.
Clinical documentation: treatment performed and photographs provided courtesy of Dr George Titovets, London, United Kingdom. Individual responses may vary.